姓名：王申
学科：预防兽医学
系别：预防兽医系
电话/传真：
电子邮件：[email protected]
通讯地址：郑州市郑东新区平安大道218号

　　王申，男，中共党员，博士，讲师，硕士研究生导师，1997年出生。主要从事新型病毒载体疫苗与黏膜免疫应答机制等方面的研究工作。以第一作者（含共同）在Signal Transduct Target Ther, Mol Ther等权威杂志发表SCI论文10篇，累计发表SCI论文23篇，参与出版著作2部，获得国家发明专利2项。

《兽医生物制品学》、《跨学科前沿》

黏膜免疫应答机制
病毒病综合防控

2022.09-2025.06  军事科学院  军事预防医学  博士
2019.09-2022.06  军事科学院  预防兽医学    硕士
2015.09-2019.06  九色视频  动物医学    学士

2025.11-至今  九色视频  九色视频  讲师

担任Advanced Science, Emerging Microbes & Infections等杂志审稿人

1. Shen Wang^#, Zhenshan Wang^#, Weiqi Wang, Hongyu Sun, Na Feng, Yongkun Zhao, Jianzhong Wang, Tiecheng Wang, Xianzhu Xia, Feihu Yan. A VSV-based oral rabies vaccine was sentineled by Peyer's patches and induced a timely and durable immune response. Mol Ther. 2025 Apr 2;33(4):1701-1719
2. Shen Wang, Wujian Li^#, Zhenshan Wang^#, Wanying Yang^#, Entao Li, Xianzhu Xia, Feihu Yan, Sandra Chiu. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control. Signal Transduct Target Ther. 2024 Sep 11;9(1):223.
3. Shen Wang^#, Bo Liang^#, Weiqi Wang^#, Ling Li^#, Na Feng, Yongkun Zhao, Tiecheng Wang, Feihu Yan, Songtao Yang, Xianzhu Xia. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. Signal Transduct Target Ther. 2023 Apr 7;8(1):149.
4. Shen Wang^#, Huan Cui^#, Cheng Zhang^#, Wujian Li, Weiqi Wang, Wenwen He, Na Feng, Yongkun Zhao, Tiecheng Wang, Xiaoqing Tang, Feihu Yan, Xianzhu Xia, Oral delivery of a chitosan adjuvanted COVID-19 vaccine provides long-lasting and broad-spectrum protection against SARS-CoV-2 variants of concern in golden hamsters. Antiviral Res, 2023: p. 105765.
5. Yu Wang^#, Shen Wang^#, Lulu Huang^#, Wenhao Mao, Fangmeng Li, Ang Lin, Weijun Zhao, Xianhuan Zeng, Yue Zhang, Dingcao Yang, Yuhong Han, Yidan Li, Leyuan Ren, Ying Li, Liang Zhang, Feihu Yan, Yong Yang, Xinying Tang. A nucleoside-modified rabies mRNA vaccine induces long-lasting and comprehensive immune responses in mice and non-human primates. Mol Ther. 2024 Dec 31: S1525-0016(24)008414.
6. Weiqi Wang^#, Shen Wang^#, Xianyong Meng^#, Yongkun Zhao, Nan Li, Tiecheng Wang, Na Feng, Feihu Yan, Xianzhu Xia. A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2. Antiviral Res. 2024 May;225:105854.
7.Qiuxue Han^#, Shen Wang^#, Zhenshan Wang^#, Cheng Zhang, Xinyue Wang, Na Feng, Tiecheng Wang, Yongkun Zhao, Hang Chi, Feihu Yan, Xianzhu Xia. Nanobodies with cross-neutralizing activity provide prominent therapeutic efficacy in mild and severe COVID-19 rodent models. Virol Sin. 2023

夜色难免黑凉，前行必有曙光